False Negative Cystic Fibrosis Newborn Screen

Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2006. Bethesda, MD: Cystic Fibrosis Foundation; 2006.

Khan TZ , Wagener JS , Bost T. , Martinez J. , Accurso FJ , Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151: 1075-1082.

Lai HJ , Cheng Y. , Farrell PM The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr. 2005;147(3 suppl):S57-S63.

Vanscoy LL , Blackman SM , Collaco JM , et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med. 2007;175:1036-1043.

Blackman SM , Deering-Brose R. , McWilliams R. , et al. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology . 2006;131:1030-1039.

Mekus F. , Ballmann M. , Bronsveld I. , Bijman J. , Veeze H. , Tummler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000;3:277-293.

Rosenstein BJ , Langbaum TS , Metz SJ Cystic fibrosis: diagnostic considerations . Johns Hopkins Med J. 1982 ;150: 113-120.

Wallis C. Diagnosis and presentation of cystic fibrosis. In: Chernick V , Boat TF , Wilmott RW , Bush A , eds. Kendig’s Disorders of the Respiratory Tract in Children . 7th ed. Philadelphia, PA : Saunders Elsevier; 2006:866-872.

Gibson LE , Cooke RE A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics . 1959;23:545-549.

Farrell PM , Rosenstein BJ , White TB , et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14.

Crossley JR , Elliott RB , Smith PA Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979;1: 472-474.

Sontag MK , Hammond KB , Zielenski J. , Wagener JS , Accurso FJ Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr. 2005;147(3 suppl):S83-S88.

Watson MS , Cutting GR , Desnick RJ , et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004;6:387-391.

Rock MJ , Hoffman G. , Laessig RH , Kopish GJ , Litsheim TJ , Farrell PM Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. J Pediatr. 2005;147(3 suppl):S73-S77.

Comeau AM , Parad RB , Dorkin HL , et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004;113: 1573-1581.

Li L. , Zhou Y. , Bell CJ , Earley MC , Hannon WH , Mei JV Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen . 2006;13:79-84.

Kloosterboer M. , Hoffman G. , Rock M. , et al. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics. 2009;123:e338-e346.